Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$735,889
in 3 filings

Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robertson Stephen P. −$736K Chief Legal Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2021-11-01 Solomons Neil Chief Medical Officer Sale −45,000 $31.64 $1.4M 137,299
2021-11-01 Solomons Neil Chief Medical Officer Option exercise · Stock Option (right to buy) −45,000 130,000
2021-11-01 Martin Michael Robert Chief Business Officer Option exercise +45,000 $3.20 $144K 221,861
2021-11-01 Martin Michael Robert Chief Business Officer Sale −45,000 $31.64 $1.4M 176,861
2021-11-01 Martin Michael Robert Chief Business Officer Option exercise · Stock Option (right to buy) −45,000 0
2021-10-25 Huizinga Robert Bindert EVP of Research Option exercise +95,000 $3.20 $304K 195,728
2021-10-25 Huizinga Robert Bindert EVP of Research Sale −130,000 $29.75 $3.9M 65,728
2021-10-25 Huizinga Robert Bindert EVP of Research Option exercise · Stock Option (right to buy) −95,000 3,864
2021-09-21 Huizinga Robert Bindert EVP of Research Option exercise +16,000 $2.63 $42K 122,092
2021-09-21 Huizinga Robert Bindert EVP of Research Option exercise +11,136 $3.20 $36K 133,228
2021-09-21 Huizinga Robert Bindert EVP of Research Sale −27,136 $24.05 $653K 106,092
2021-09-21 Huizinga Robert Bindert EVP of Research Sale −5,364 $23.66 $127K 100,728
2021-09-21 Huizinga Robert Bindert EVP of Research Option exercise · Stock Option (right to buy) −16,000 0
2021-09-21 Huizinga Robert Bindert EVP of Research Option exercise · Stock Option (right to buy) −11,136 98,864
2021-09-21 Martin Michael Robert Chief Business Officer Option exercise +7,500 $5.30 $40K 184,361
2021-09-21 Martin Michael Robert Chief Business Officer Option exercise +70,000 $6.06 $424K 254,361
2021-09-21 Martin Michael Robert Chief Business Officer Option exercise +10,000 $18.38 $184K 264,361
2021-09-21 Martin Michael Robert Chief Business Officer Sale −87,500 $24.02 $2.1M 176,861
2021-09-21 Martin Michael Robert Chief Business Officer Option exercise · Option Grant (right to buy) −7,500 0
2021-09-21 Martin Michael Robert Chief Business Officer Option exercise · Option Grant (right to buy) −70,000 0

Page 14 of 18 · 345 trades